NCT02842359 - Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 23, 2016

Primary Completion Date

April 19, 2018

Study Completion Date

April 19, 2018

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Irbesartan/atorvastatin fixed dose combination

Pharmaceutical form:Tablet Route of administration: Oral

DRUG

Irbesartan SR47436

Pharmaceutical form:Tablet Route of administration: Oral

DRUG

Atorvastatin

Pharmaceutical form:Tablet Route of administration: Oral

Trial Locations (1)

Korea, Seoul